Immatics N.V.
IMTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001809196
In the last 90 days, Immatics N.V. insiders filed 1 open-market purchase and 0 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $1.01B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Immatics N.V. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 47 | 49 | +2 |
| Shares | 21.7M | 21.5M | −190.4K (−0.9%) |
| Value | $173.0M | $186.9M | +$13.9M (+8.1%) |
New holders (9)
Institutions that held Immatics N.V. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rock Springs Capital Management LP | 1,127,970 | $9.82M | 0.29% |
| Citadel Advisors LLC | 54,299 | $473.0K | 0.00% |
| Corton Capital Inc. | 36,619 | $319.0K | 0.30% |
| Delphia (USA) Inc. | 34,662 | $302.0K | 0.21% |
| Jane Street Group, LLC | 13,206 | $115.0K | 0.00% |
| Trexquant Investment LP | 11,253 | $98.0K | 0.00% |
| Marshall Wace, LLP | 10,693 | $94.0K | 0.00% |
| Wolverine Asset Management LLC | 4,854 | $42.0K | 0.00% |
| Simplex Trading, LLC | 867 | $7.00K | 0.00% |
Sold out (7)
Institutions that held Immatics N.V. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Woodline Partners LP | 319,480 | $2.55M |
| State Street Corp | 94,898 | $758.0K |
| Goldman Sachs Group Inc | 25,243 | $202.0K |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 24,865 | $199.0K |
| Gsa Capital Partners LLP | 13,343 | $107.0K |
| Two Sigma Advisers, LP | 11,300 | $90.0K |
| MYDA Advisors LLC | 10,000 | $80.0K |